Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 protein-coding genes, only about 4,500 are ...

When probes are inserted into the brain for research or clinical purposes, the electrical activity of neurons is recorded.

Automation, AI, and human organoids enable researchers to move away from outdated 2D cell cultures and animal models, ...

Cambridge expertise has been intrinsic to a world first – loading a complete genome onto a quantum computer. The milestone ...

When a child’s symptoms stump one specialist after another for years on end, families describe the experience as grueling and ...

The entire genome of the D-type hepatitis virus, which is transmitted through blood or bodily fluids, has been successfully ...

Afforestation—establishing forests on previously non-forested land, or where forests have not existed for a long time—is one ...

A team of scientists from NTU Singapore has developed a new biochip that, when paired with artificial intelligence, can ...

Discover how a new nanophotonic chip uses genetic markers and AI to detect diseases in minutes, potentially revolutionising ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...

As Artificial Intelligence matures from a tool into a reality, we have traded the nosy neighbor for a clinical, invisible, ...

Engineered cells are a high-value genetic asset that is key to many fields, including biotechnology, medicine, aging, and ...